线粒体DNA突变者行植入前遗传学检测:卵巢刺激反应、结局及随访
法国单中心回顾性研究(2006年1月至2021年7月)比较18例因母系遗传线粒体DNA疾病行植入前遗传学检测(PGT)的女性与96例男性指征PGT对照者的卵巢储备和刺激周期结局,发现两组卵巢反应参数无差异,但mtDNA组所需刺激时间更长、促性腺激素剂量更高;3例(16.7%)经PGT活产,8例(44.4%)通过供卵、自然受孕加产前诊断或领养获得亲子关系。
要点
- 线粒体DNA突变携带者卵巢刺激反应参数与男性指征PGT对照无差异。
- 线粒体DNA突变携带者所需卵巢刺激时间更长、促性腺激素剂量更高。
- 3例(16.7%)经PGT活产,8例(44.4%)通过替代方法获得亲子关系。
核心结论
- 据作者所知,这是首项关于携带线粒体DNA变异女性接受单基因病PGT的研究,PGT是获得健康婴儿的可能选择之一,且未见卵巢刺激反应受损。
研究设计与样本
- 法国单中心回顾性研究,纳入2006年1月至2021年7月因母系遗传线粒体DNA疾病行PGT的18例(mtDNA-PGT组),与96例男性指征PGT匹配对照进行比较。
主要发现
- mtDNA-PGT组卵巢对FSH的反应参数及刺激周期结局与匹配对照无差异。
- mtDNA-PGT组需要更长的卵巢刺激时间和更高的促性腺激素剂量。
- mtDNA-PGT组3例(16.7%)经PGT过程获得活产。
- mtDNA-PGT组8例(44.4%)通过替代方法获得亲子关系:供卵4例、自然受孕加产前诊断2例、领养2例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: How do carriers of pathogenic mitochondrial DNA (mtDNA) respond to ovarian stimulation? DESIGN: A single-centre, retrospective study conducted between January 2006 and July 2021 in France. Ovarian reserve markers and ovarian stimulation cycle outcomes were compared for couples undergoing preimplantation genetic testing (PGT) for maternally inherited mtDNA disease (n = 18) (mtDNA-PGT group) with a matched-control group of patients undergoing PGT for male indications (n = 96). The PGT outcomes for the mtDNA-PGT group and the follow-up of these patients in case of unsuccessful PGT was also reported. RESULTS: For carriers of pathogenic mtDNA, parameters of ovarian response to FSH and ovarian stimulation cycle outcomes were not different from those of matched-control ovarian stimulation cycles. The carriers of pathogenic mtDNA needed a longer ovarian stimulation and higher dose of gonadotrophins. Three patients (16.7%) obtained a live birth after the PGT process, and eight patients (44.4%) achieved parenthood through alternative methods: oocyte donation (n = 4), natural conception with prenatal diagnosis (n = 2) and adoption (n = 2). CONCLUSION: To the best of our knowledge, this is the first study of women carrying a mtDNA variant who have undergone a PGT for monogenic (single gene defects) procedure. It is one of the possible options to obtain a healthy baby without observing an impairment in ovarian response to stimulation.
引用
- Mayeur A, Benaloun E, Benguigui J, et al. Preimplantation genetic testing for mitochondrial DNA mutation: ovarian response to stimulation, outcomes and follow-up. Reprod Biomed Online. 2023. PMID: 37202317. doi:10.1016/j.rbmo.2023.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。